kitio.aiArteraAI vs DeepScribe
A side-by-side look at pricing plans, free tiers, features, pros and cons, updated for 2026. ArteraAI starts at See pricing page and DeepScribe starts at See pricing page. Check both pricing pages for current plans.
At a glance
Best for
Pricing model
Starting price
Free plan
Made by
Based in
Rating
Key features
- Prostate cancer risk test
- Breast cancer test
- Uses existing H&E slides
- 1-2 day turnaround
- Online ordering portal
- Ambient visit recording
- Specialty-tuned notes
- Coding support
- Quality measure capture
- EHR sync
| Feature | ArteraAI | DeepScribe |
|---|---|---|
| Best for | AI pathology tests that predict cancer outcomes and therapy benefit | Ambient AI medical scribe with specialty-tuned clinical notes |
| Category | Legal, finance & HR | Legal, finance & HR |
| Pricing model | Paid | Paid |
| Starting price | See pricing page | See pricing page |
| Free plan | No | No |
| Made by | Artera | DeepScribe |
| Based in | United States | United States |
| Rating | No ratings yet | No ratings yet |
| Key features |
|
|
Pricing compared
ArteraAI starts at See pricing page and DeepScribe starts at See pricing page. Check both pricing pages for current plans.
Free plan
Cheapest paid plan
Top plan
Free trial
Prices in USD, checked Oct 28, 2026 or later. Plans change often, so confirm on each tool's site before you buy.
Pros and cons
ArteraAI
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
- Ordered by clinicians only
- Covers few cancer types so far
- Cost depends on insurance coverage
DeepScribe
- Detailed specialty notes
- Adapts to clinician style
- Good for oncology practices
- No free trial
- Higher price than consumer scribes
- Sales-led onboarding
Which one should you choose?
Choose ArteraAI if you want:
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
Watch out: ordered by clinicians only.
Choose DeepScribe if you want:
- Detailed specialty notes
- Adapts to clinician style
- Good for oncology practices
Watch out: no free trial.
ArteraAI vs DeepScribe FAQ
What is the difference between ArteraAI and DeepScribe?
ArteraAI: AI pathology tests that predict cancer outcomes and therapy benefit. DeepScribe: Ambient AI medical scribe with specialty-tuned clinical notes. Both are legal, finance & hr tools.
Is ArteraAI or DeepScribe cheaper?
ArteraAI starts at See pricing page and DeepScribe starts at See pricing page. Check both pricing pages for current plans.
Do ArteraAI and DeepScribe have free plans?
ArteraAI: No. DeepScribe: No.
Who makes ArteraAI?
ArteraAI is made by Artera, based in United States.
Who makes DeepScribe?
DeepScribe is made by DeepScribe, based in United States.
Which should I choose, ArteraAI or DeepScribe?
Choose ArteraAI if you value fda de novo authorization and listed in nccn prostate guidelines. Choose DeepScribe if you value detailed specialty notes and adapts to clinician style.